Skip to main content

The PCB hosts the 9th edition of the PhysChem Forum

By 15 de September de 2010November 18th, 2020No Comments
< Back to news

The PCB hosts the 9th edition of the PhysChem Forum

The 9th edition of the PhysChem Forum will be held tomorrow and the next day, September 16th and through17th. The program, which will start on the 16th at Hotel Husa Illa with an opening conference by professor Chris Hunter of the University of Sheffield, will take place entirely on the 17th at the Antoni Caparros Auditorium of the Barcelona Science Park.

The main objective of the Forum, which has been held since 2005, is to open a space that facilitates debate and interaction between companies and the academic world and to promote multidisciplinary teamwork in the field of applied physical chemistry.

The Forum´s committee, formed by researchers from the academic and business sectors who have a wealth of experience in the field of physical chemistry, includes doctors Antoni Llinàs (AstraZeneca), Nicola Colclough (AstraZeneca), Jonathan Burley (University of Nottingham) Darren Edwards (Organon) Alan Hill (GSK) Joerg Keldenich (Bayer HealthCare), Barbara Mason (PhysChem Consulting), Peter Olsen (NeuroSearch), Martin Stuart (Sirius Analytical), Kiyohiko Sugano (Pfizer) and Caroline Ward (Phytopharm).

This is the first time that the PhysChem Forum Committee entrusts an academic body such as the University of Barcelona with the responsibility of co-organising the event which will the first to take place outside its normal setting.

The session on the 17th at the Antonio Caparros Auditorium will be attended by the vice-rector of Research of the UB, Jordi Alberch. The moderators will be Antoni Llinàs (Astra Zeneca) and Jonathan Burley (University of Nottingham). In addition, ten internationally renowned experts will also be participating in the programme.

The oral presentations cover the latest aspects in the field of thermodynamics associated with the formation of co-crystals, the engineering involved in the obtention of crystals and solubility of active principles and the identification of in vivo prediction tools for the assessment of drug bioavailability in their different administration modalities. In addition, there will be presentations addressing versatile methods, such as the measurement of interactions between active principles and membrane proteins, as tools for the study of drug performance. The cycle of presentations will be complemented with the presentation of over twenty posters.